Compendium of Cancer Genome Aberrations

FEMA5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
No edit summary
 
(11 intermediate revisions by the same user not shown)
Line 6: Line 6:


To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
__TOC__
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Female Genital Tumours (5th Edition) Content</big>
|+<big>WHO Classification of Female Genital Tumours (5th Edition) Content</big>
Line 16: Line 18:
!'''Date of Last Editor Review'''
!'''Date of Last Editor Review'''
!'''Notes'''
!'''Notes'''
|-
|
==== CHAPTER 2 (TUMOURS OF THE OVARY) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[FEMA5:Serous_cystadenoma,_adenofibroma,_and_surface_papilloma_of_the_ovary|Serous cystadenoma, adenofibroma, and surface papilloma of the ovary]]
|[[FEMA5:Serous_cystadenoma,_adenofibroma,_and_surface_papilloma_of_the_ovary|Serous cystadenoma, adenofibroma, and surface papilloma of the ovary]]
Line 786: Line 809:
|
|
|
|
|-
|
==== CHAPTER 3 (ENDOMETRIOSIS AND RELATED CONDITIONS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[FEMA5:Endometriosis_and_derived_tumours|Endometriosis and derived tumours]]
|[[FEMA5:Endometriosis_and_derived_tumours|Endometriosis and derived tumours]]
Line 797: Line 841:
|
|
|
|
|-
|
==== CHAPTER 4 (TUMOURS OF THE PERITONEUM) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[FEMA5:Adenomatoid_tumour_|Adenomatoid tumour]]
|[[FEMA5:Adenomatoid_tumour_|Adenomatoid tumour]]
Line 1,062: Line 1,127:
|
|
|-
|-
|[[FEMA5:Serous_adenofibroma_and_papilloma_of_the_fallopian_tube|Serous adenofibroma and papilloma of the fallopian tube]]
|
|Disease
==== CHAPTER 5 (TUMOURS OF THE FALLOPIAN TUBE) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[FEMA5:Serous_adenofibroma_and_papilloma_of_the_fallopian_tube|Serous adenofibroma and papilloma of the fallopian tube]]
|Disease
|
|
|
|
Line 1,215: Line 1,301:
|
|
|
|
|-
|
==== CHAPTER 6 (TUMOURS OF THE BROAD LIGAMENT AND OTHER UTERINE LIGAMENTS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[FEMA5:Leiomyoma_of_the_broad_ligament_and_other_uterine_ligaments|Leiomyoma of the broad ligament and other uterine ligaments]]
|[[FEMA5:Leiomyoma_of_the_broad_ligament_and_other_uterine_ligaments|Leiomyoma of the broad ligament and other uterine ligaments]]
Line 1,303: Line 1,410:
|
|
|
|
|-
|
==== CHAPTER 7 (TUMOURS OF THE UTERINE CORPUS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[FEMA5:Endometrial_hyperplasia_without_atypia|Endometrial hyperplasia without atypia]]
|[[FEMA5:Endometrial_hyperplasia_without_atypia|Endometrial hyperplasia without atypia]]
Line 1,623: Line 1,751:
|
|
|-
|-
|[[FEMA5:Exaggerated_placental_site_reaction|Exaggerated placental site reaction]]
|
|Disease
==== CHAPTER 8 (GESTATIONAL TROPHOBLASTIC DISEASE) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[FEMA5:Exaggerated_placental_site_reaction|Exaggerated placental site reaction]]
|Disease
|
|
|
|
Line 1,732: Line 1,881:
|
|
|
|
|-
|
==== CHAPTER 9 (TUMOURS OF THE UTERINE CERVIX) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[FEMA5:Squamous_metaplasia|Squamous metaplasia]]
|[[FEMA5:Squamous_metaplasia|Squamous metaplasia]]
Line 2,073: Line 2,243:
|
|
|
|
|-
|
==== CHAPTER 10 (TUMOURS OF THE VAGINA) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[FEMA5:Squamous_papilloma_of_the_vagina|Squamous papilloma of the vagina]]
|[[FEMA5:Squamous_papilloma_of_the_vagina|Squamous papilloma of the vagina]]
Line 2,327: Line 2,518:
|
|
|-
|-
|[[FEMA5:Seborrhoeic_keratosis|Seborrhoeic keratosis]]
|
|Disease
==== CHAPTER 11 (TUMOURS OF THE VULVA) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[FEMA5:Seborrhoeic_keratosis|Seborrhoeic keratosis]]
|Disease
|
|
|
|
Line 2,535: Line 2,747:
|
|
|
|
|-
|
==== CHAPTER 12 (NEUROENDOCRINE NEOPLASIA) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[FEMA5:Neuroendocrine_tumour|Neuroendocrine tumour]]
|[[FEMA5:Neuroendocrine_tumour|Neuroendocrine tumour]]
Line 2,579: Line 2,812:
|
|
|
|
|-
|
==== CHAPTER 13 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[FEMA5:Florid_reactive_lymphoid_hyperplasia|Florid reactive lymphoid hyperplasia]]
|[[FEMA5:Florid_reactive_lymphoid_hyperplasia|Florid reactive lymphoid hyperplasia]]
Line 2,646: Line 2,900:
|
|
|-
|-
|[[FEMA5:Lipoma_|Lipoma]]
|
|Disease
==== CHAPTER 14 (MESENCHYMAL TUMOURS OF THE LOWER GENITAL TRACT) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[FEMA5:Lipoma_|Lipoma]]
|Disease
|
|
|
|
Line 2,943: Line 3,218:
|
|
|-
|-
|[[FEMA5:Acquired_melanocytic_naevus|Acquired melanocytic naevus]]
|Disease
|
|
==== CHAPTER 15 (MELANOCYTIC LESIONS) ====
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[FEMA5:Congenital_melanocytic_naevus_|Congenital melanocytic naevus]]
|[[FEMA5:Acquired_melanocytic_naevus|Acquired melanocytic naevus]]
|Disease
|Disease
|
|
Line 2,965: Line 3,250:
|
|
|-
|-
|[[FEMA5:Blue_naevus_|Blue naevus]]
|[[FEMA5:Congenital_melanocytic_naevus_|Congenital melanocytic naevus]]
|Disease
|Disease
|
|
Line 2,976: Line 3,261:
|
|
|-
|-
|[[FEMA5:Atypical_melanocytic_naevus_of_genital_type_|Atypical melanocytic naevus of genital type]]
|[[FEMA5:Blue_naevus_|Blue naevus]]
|Disease
|Disease
|
|
Line 2,987: Line 3,272:
|
|
|-
|-
|[[FEMA5:Dysplastic_melanocytic_naevus_|Dysplastic melanocytic naevus]]
|[[FEMA5:Atypical_melanocytic_naevus_of_genital_type_|Atypical melanocytic naevus of genital type]]
|Disease
|Disease
|
|
Line 2,998: Line 3,283:
|
|
|-
|-
|[[FEMA5:Mucosal_melanoma_|Mucosal melanoma]]
|[[FEMA5:Dysplastic_melanocytic_naevus_|Dysplastic melanocytic naevus]]
|Disease
|Disease
|
|
Line 3,009: Line 3,294:
|
|
|-
|-
|[[FEMA5:Metastasis_to_the_lower_female_genital_tract|Metastasis to the lower female genital tract]]
|[[FEMA5:Mucosal_melanoma_|Mucosal melanoma]]
|Disease
|Disease
|
|
Line 3,020: Line 3,305:
|
|
|-
|-
|[[FEMA5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]
|Disease
|
|
==== CHAPTER 16 (METASTASIS) ====
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[FEMA5:Lynch_syndrome|Lynch syndrome]]
|[[FEMA5:Metastasis_to_the_lower_female_genital_tract|Metastasis to the lower female genital tract]]
|Disease
|Disease
|
|
Line 3,042: Line 3,337:
|
|
|-
|-
|[[FEMA5:Cowden_syndrome|Cowden syndrome]]
|Disease
|
|
==== CHAPTER 17 (GENETIC TUMOUR SYNDROMES OF THE FEMALE GENITAL TRACT) ====
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|[[FEMA5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[FEMA5:Lynch_syndrome|Lynch syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[FEMA5:Cowden_syndrome|Cowden syndrome]]
|Disease
|[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|-
|[[FEMA5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|[[FEMA5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[FEMA5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
|[[FEMA5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[FEMA5:Ataxia-telangiectasia|Ataxia-telangiectasia]]
|[[FEMA5:Ataxia-telangiectasia|Ataxia-telangiectasia]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[FEMA5:Carney_complex|Carney complex]]
|[[FEMA5:Carney_complex|Carney complex]]
Line 3,099: Line 3,437:
|[[FEMA5:DICER1_syndrome_|DICER1 syndrome]]
|[[FEMA5:DICER1_syndrome_|DICER1 syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[FEMA5:Ovarian_dysgenesis|Ovarian dysgenesis]]
|[[FEMA5:Ovarian_dysgenesis|Ovarian dysgenesis]]
Line 3,120: Line 3,458:
|-
|-
|[[FEMA5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|[[FEMA5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[FEMA5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma|Hereditary leiomyomatosis and renal cell carcinoma]]
|Disease
|Disease
|
|
Line 3,130: Line 3,479:
|
|
|-
|-
|[[FEMA5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma|Hereditary leiomyomatosis and renal cell carcinoma]]
|[[FEMA5:Other genetic tumour syndromes of the female genital tract|Other genetic tumour syndromes of the female genital tract]]
|Disease
|Disease
|
|
Retrieved from "https://test.ccga.io/index.php/FEMA5:Volunteer_Assignments_and_Opportunities"